Skip to main navigation Skip to search Skip to main content

Technetium-99m MDP bone scintigraphic findings of hypercalcemia in accelerated phase of Chronic Myelogenous Leukemia

  • Jeonbuk National University

Research output: Contribution to journalJournal articlepeer-review

Abstract

Hypercalcemic in accelerated phase of chronic myelogenous leukemia (CML) is very rare. Its pathogenesis is considered humoral hypercalcemia of malignancies mediated by parathyroid hormone-related protein (PTHrP). In severe hypercalcemia, calcifications in kidneys, skin, vessels, heart, and stomach may occur. Our two cases were admitted because of severe hypercalcemia in accelerated phase of CML. On Tc-99m methylene diphosphonate (MDP) bone scintigraphies, a marked tracer accumulation was seen in the lung, heart, stomach and kidney. We report increased tracer accumulation of multiple organs on Tc-99m MDP bone scintigraphy in two rare hypercalcemic patients with CML.

Original languageEnglish
Pages (from-to)598-600
Number of pages3
JournalJournal of Korean Medical Science
Volume15
Issue number5
DOIs
StatePublished - 2000.10

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Hypercalcemic
  • Leukemia, Myeloid, Chronic
  • Radionuclide Imaging

Quacquarelli Symonds(QS) Subject Topics

  • Medicine

Fingerprint

Dive into the research topics of 'Technetium-99m MDP bone scintigraphic findings of hypercalcemia in accelerated phase of Chronic Myelogenous Leukemia'. Together they form a unique fingerprint.

Cite this